LinkedIn co-founder Reid Hoffman is stepping down from Microsoft's board of directors following the 2026 shareholder vote. He plans to dedicate more time to Manas, his AI-powered drug discovery startup. This move signifies a shift in his focus towards advancing AI in the pharmaceutical sector. AI
IMPACT A key figure in tech is shifting focus to AI-driven drug discovery, potentially accelerating innovation in that sector.
RANK_REASON A prominent tech figure is stepping down from a major tech company's board to focus on a new venture.
Read on Mastodon — mastodon.social →
AI-generated summary · Google Gemini · from 2 sources. How we write summaries →
